Development of a headspace gas chromatographic test for the quantification of 1- and 2-bromopropane in human urine

• Published in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2005-01, Vol.814 (1), p.185-189
• Main Authors: B’Hymer, C., Cheever, K.L.
• Format: Article
• Language: English
• Subjects: 1-Bromopropane; 2-Bromopropane; Analysis; Analytical, structural and metabolic biochemistry; Biological and medical sciences; Chromatography, Gas - methods; Fundamental and applied biological sciences. Psychology; General pharmacology; Humans; Hydrocarbons, Brominated - urine; Medical sciences; Pharmacology. Drug treatments; Reference Standards; Reproducibility of Results
• ISSN: 1570-0232; 1873-376X
• DOI: 10.1016/j.jchromb.2004.10.045

A test procedure was developed for the detection and quantification of 1- and 2-bromopropane in human urine. 1-Bromopropane (1-BP) is a commonly used industrial solvent, and 2-bromopropane (2-BP) is often found as an impurity component in industrial grade 1-BP. Both compounds are a health concern for exposed workers due to their chronic toxicity. Bromopropanes have been associated with neurological disorders in both animals and humans. Sample preparation consisted of diluting urine with water and fortification with 1-bromobutane (1-BB), which was used as an internal standard; then each sample was sealed in a headspace vial. A static-headspace sampler (Teledyne-Tekmar Model 7000) was used to heat each sample at 75 °C for a 35-min equilibrium time. Quantification was by means of a gas chromatograph (GC) equipped with an electron capture detector (ECD) and a dimethylpolysiloxane (DB-1) capillary column. A recovery study using fortified urine samples at multiple concentrations (0.5–8 μg/ml) demonstrated full recovery; 104–121% recovery was obtained. Precision ranged from 5 to 17% for the 15–20 spiked samples used at each concentration, which were analyzed over multiple experimental trial days. The limit of detection (LOD) for this test procedure was approximately 2 ng/ml 1-BP and 7 ng/ml 2-BP in urine. A recovery study of 1- and 2-BP from fortified urine stored in vials appropriate for field collection was also completed. These results and other factors of the development and validation of this test procedure will be discussed.